Zurcher Kantonalbank »

Taysha Gene Therapies shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2025-12-31 $371k 68k 5.50

More positions owned by Zurcher Kantonalbank

Nvidia Corporation Note 2.500% 4/ (NVDA)
Apple Cl A (AAPL)
Microsoft Corporation (MSFT)
Ubs Group Call (UBS)
Amazon Put (AMZN)
Alphabet Call (GOOGL)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Shs New (GOOG)
Meta Platforms Call (META)
Jpmorgan Chase & Co. Call (JPM)
Eli Lilly & Co Call (LLY)
Alcon SHS (ALC)
Amrize Put (AMRZ)
Visa Com Cl A (V)

View all positions for Zurcher Kantonalbank

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies